- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06547138
Pilotstudie naar de effectiviteit en veiligheid van OPTILENE® SILVER MESH ELASTIC bij de preventie van infectie op de operatieplaats (SSI) en littekenbreuk (IH) (SSIHLVER)
Prospectief beschrijvend multicentrisch pilotonderzoek naar de effectiviteit en veiligheid van Optilene® Silver Mesh Elastic bij de preventie van infectie op de operatieplaats (SSI) en littekenbreuk (IH)
The aim of the study is to describe the effectiveness of Optilene® Silver Mesh Elastic on prevention of surgical site infection (SSI) at 6 months follow-up in patients undergoing urgent laparotomy by collecting clinical data on the SSI rates, IH rates and overall clinical performance of Optilene® Silver Mesh Elastic used for the prevention of incisional hernia as prophylactic mesh in patients that require urgent median laparotomy in clinical routine.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Irene Fita Esteban
- Telefoonnummer: +34609054401
- E-mail: info@bbraun.com
Studie Contact Back-up
- Naam: José Manuel Molina Villar
- Telefoonnummer: +34697502623
- E-mail: info@bbraun.com
Studie Locaties
-
-
-
Badalona, Spanje, 08916
- Hospital Universitari Germans Tries i Pujol
-
Contact:
- Joan Francesc Julián, Dr.
-
Hoofdonderzoeker:
- Joan Francesc Julián, Dr.
-
Badalona, Spanje
- Hospital Municipal Badalona
-
Contact:
- Jorge Marroquin, Dr.
-
Hoofdonderzoeker:
- Jorge Marroquin, Dr.
-
Calella, Spanje, 08370
- Hospital Comarcal Sant Jaume de Calella
-
Contact:
- Paqui Vasco, Dr.
-
Hoofdonderzoeker:
- Paqui Vasco, Dr.
-
Mataró, Spanje, 08304
- Hospital de Mataró
-
Contact:
- Berhanu Chimdi, Dr.
-
Hoofdonderzoeker:
- Berhanu Chimdi, Dr.
-
Santa Coloma de Gramenet, Spanje, 08923
- Hospital Fundació Esperit Sant
-
Contact:
- Daniel Troyano Escribano, Dr.
-
Hoofdonderzoeker:
- Daniel Troyano Escribano, Dr.
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
High-risk patients according to the professional criteria (such as but not limited to: age, nutrition, body mass index, comorbidities, etc.) who are undergoing prophylactic mesh implantation to avoid surgical site infection after an emergency or urgent intra-abdominal laparotomy.
Beschrijving
Inclusion Criteria:
- Adult patients (18 years or older)
- Surgical procedure requiring urgent, primary median laparotomy, which are classified as "Class III/Contaminated" or "Class IV/Dirty-Infected" regarding the CDC classification.
These include but are not limited to:
-
Vascular surgery
-
Colon and rectum
-
Hepatobiliary
-
Gastrointestinal
-
Gynecology
-
Urology
-
Abdominal Aortic Aneurysm (AAA) repair
-
Right hemicolectomy
-
Left hemicolectomy
-
Sigmoidectomy
-
Anterior resection
-
Abdominoperineal amputation
-
Exploratory laparotomy
-
Cholecystectomy
-
Cholecystectomy and choledocotomy
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Breast feeding
- Patients < 18 years old or patients who are still in the growth phase
- Contaminated and infected areas
- Hypersensitivity to silver
- Direct contact with the viscera
- Previous allergic reactions to components of the device
- Patient with previous laparotomy
- Transverse laparotomy
- Patients with previous hernia repair
- Simultaneous participation in another investigational clinical trial (drug or medical studies)
- Patients with active oncologic treatment (chemo and radiotherapy)
- Underlying autoimmune disease
- Recent cardiovascular complication
- Gynecology surgery
- Urology surgery
- Vascular surgery
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Optilene® Silver Mesh Elastic
Prophylactic mesh in high-risk patients |
Prevention of incisional hernia after a prophylactic mesh in high-risk patients |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Surgical Site Infection (SSI) A2/A3 rate
Tijdsspanne: at 6 months follow-up
|
SSIs remain a significant clinical problem as they are associated with substantial mortality and morbidity and impose severe demands on healthcare resources. Centers for Disease Control and Prevention Surgical Site Infection (SSI) Classification System differentiates Superficial SSI (A1), Deep Incisional SSI (A2) and Infection with involvement of organs/body cavities (A3). Only cases of A2 and A3 are considered for the Primary Outcome and are compared to rates from reference literature |
at 6 months follow-up
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cumulative rate of of postoperative complications during the study period
Tijdsspanne: at discharge (up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up
|
Numbers of all postoperative complications such as mortality, burst abdomen, bowel obstruction, bulging, necrosis, fistula, wound dehiscence, hematoma, seroma, peritonitis are added to the overall complication rate that is observed over the postoperative course |
at discharge (up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up
|
|
Cumulative Surgical Site Infection (SSI) A2/A3 rate during the study period
Tijdsspanne: at 1 month, 1 year and 2 year follow-up.
|
Number of the Surgical Site Infection (SSI) (only A2 and A3) rate at every follow-up |
at 1 month, 1 year and 2 year follow-up.
|
|
Incisional hernia (IH) rate during the study period
Tijdsspanne: repeatedly at 6 months, 1 year and 2 year follow-up.
|
Incisional hernia (IH) is a protrusion of tissue that forms at the site of a healing surgical scar. Incisional hernia refers to abdominal wall hernia at the site of a previous surgical incision. |
repeatedly at 6 months, 1 year and 2 year follow-up.
|
|
Length of hospital stay
Tijdsspanne: at discharge (approximately up to 10 days after surgery)
|
Number of days the patient has to stay in hospital after the surgery |
at discharge (approximately up to 10 days after surgery)
|
|
Development of Pain: Visual Analogue Scale (VAS)
Tijdsspanne: at discharge (approximately up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up, using the VAS score
|
This parameter will be noted using the Visual Analogue Scale (VAS) which state "0" at one end representing "no pain" and "100" at the opposite end representing "heavy pain". |
at discharge (approximately up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up, using the VAS score
|
|
Time to return to work
Tijdsspanne: at all postoperative examinations with a single value for each individual patient
|
The number of days needed to return to work after the surgery of the individual patient is documented |
at all postoperative examinations with a single value for each individual patient
|
|
Handling of the Optilene® Silver Mesh Elastic
Tijdsspanne: intraoperatively
|
The handling will be evaluated using a questionnaire (Likert-type scale) with the dimensions Tensile Strength, Absence of memory effect, Elasticity, Stiffness, Surface weight, Thickness, Ease of being fixed with suture, Ease of package extraction as well as an overall opinion in five evaluation levels (excellent=1, very good=2, good=3, satisfied=4, poor=5) |
intraoperatively
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Daniel Troyano Escribano, Dr., Fundació Hospital de l'Esperit Sant
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- AAG-G-H-2126
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .